BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9152521)

  • 1. Changes in biomarker expression in the development of prostatic adenocarcinoma.
    Myers RB; Grizzle WE
    Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker expression in prostatic intraepithelial neoplasia.
    Myers RB; Grizzle WE
    Eur Urol; 1996; 30(2):153-66. PubMed ID: 8875196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
    J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
    Poczatek RB; Myers RB; Manne U; Oelschlager DK; Weiss HL; Bostwick DG; Grizzle WE
    J Urol; 1999 Oct; 162(4):1462-6. PubMed ID: 10492238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
    Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
    Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
    Xie W; Wong YC; Tsao SW
    Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG; Qian J; Maihle NJ
    Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma.
    Myers RB; Srivastava S; Oelschlager DK; Brown D; Grizzle WE
    Hum Pathol; 1996 Oct; 27(10):1021-4. PubMed ID: 8892585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
    Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
    Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
    Parsons JK; Gage WR; Nelson WG; De Marzo AM
    Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
    Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
    J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of prostatic intraepithelial neoplasia.
    Bostwick DG; Pacelli A; Lopez-Beltran A
    Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
    Tennant MK; Thrasher JB; Twomey PA; Birnbaum RS; Plymate SR
    J Clin Endocrinol Metab; 1996 Jan; 81(1):411-20. PubMed ID: 8550786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
    Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
    J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.